Eman A. M. Beshr

857 total citations
38 papers, 700 citations indexed

About

Eman A. M. Beshr is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Eman A. M. Beshr has authored 38 papers receiving a total of 700 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Organic Chemistry, 12 papers in Molecular Biology and 4 papers in Pharmacology. Recurrent topics in Eman A. M. Beshr's work include Synthesis and biological activity (24 papers), Click Chemistry and Applications (8 papers) and Synthesis and Characterization of Heterocyclic Compounds (7 papers). Eman A. M. Beshr is often cited by papers focused on Synthesis and biological activity (24 papers), Click Chemistry and Applications (8 papers) and Synthesis and Characterization of Heterocyclic Compounds (7 papers). Eman A. M. Beshr collaborates with scholars based in Egypt, Saudi Arabia and Türkiye. Eman A. M. Beshr's co-authors include Mohamed Abdel‐Aziz, Gamal El‐Din A. Abuo‐Rahma, Taha F. S. Ali, Mai E. Shoman, Omar M. Aly, Al‐Shaimaa F. Ahmed, Tamer S. Kaoud, Samar H. Abbas, Hassan H. Farag and Aboul‐Fetouh E. Mourad and has published in prestigious journals such as International Journal of Molecular Sciences, Molecules and European Journal of Medicinal Chemistry.

In The Last Decade

Eman A. M. Beshr

36 papers receiving 690 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eman A. M. Beshr Egypt 18 529 212 92 79 64 38 700
G. Bharath Kumar India 19 695 1.3× 286 1.3× 102 1.1× 63 0.8× 75 1.2× 30 888
Omaima M. Abdelhafez Egypt 12 407 0.8× 194 0.9× 117 1.3× 42 0.5× 48 0.8× 17 548
Ola I. A. Salem Egypt 14 418 0.8× 217 1.0× 62 0.7× 58 0.7× 76 1.2× 26 586
María Kimatrai Salvador Italy 18 686 1.3× 251 1.2× 67 0.7× 53 0.7× 87 1.4× 23 815
Ehab M. Gedawy Egypt 14 405 0.8× 303 1.4× 87 0.9× 43 0.5× 89 1.4× 29 640
Kashif Haider India 14 334 0.6× 246 1.2× 52 0.6× 56 0.7× 74 1.2× 23 643
C. V. Kavitha India 19 660 1.2× 354 1.7× 78 0.8× 49 0.6× 99 1.5× 40 1.0k
Viswanath Arutla India 15 571 1.1× 265 1.3× 65 0.7× 28 0.4× 57 0.9× 27 774
Zulphikar Ali India 9 657 1.2× 241 1.1× 40 0.4× 78 1.0× 99 1.5× 12 802
Sultan Nacak Baytaş Türkiye 17 477 0.9× 267 1.3× 84 0.9× 30 0.4× 51 0.8× 34 694

Countries citing papers authored by Eman A. M. Beshr

Since Specialization
Citations

This map shows the geographic impact of Eman A. M. Beshr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eman A. M. Beshr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eman A. M. Beshr more than expected).

Fields of papers citing papers by Eman A. M. Beshr

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eman A. M. Beshr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eman A. M. Beshr. The network helps show where Eman A. M. Beshr may publish in the future.

Co-authorship network of co-authors of Eman A. M. Beshr

This figure shows the co-authorship network connecting the top 25 collaborators of Eman A. M. Beshr. A scholar is included among the top collaborators of Eman A. M. Beshr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eman A. M. Beshr. Eman A. M. Beshr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
El‐Hafeez, Amer Ali Abd, Taha F. S. Ali, Ahmed M. Sayed, et al.. (2024). New 2-oxoindole derivatives as multiple PDGFRα/ß and VEGFR-2 tyrosine kinase inhibitors. Bioorganic Chemistry. 145. 107234–107234. 4 indexed citations
3.
Ali, Taha F. S., et al.. (2023). New antiproliferative 3-substituted oxindoles inhibiting EGFR/VEGFR-2 and tubulin polymerization. Molecular Diversity. 28(2). 563–580. 20 indexed citations
4.
Abdel‐Aziz, Mohamed, et al.. (2023). Chalcone Scaffold: A masterpiece for medicinal chemistry recent biological insights. 0(0). 90–96.
5.
Amin, Mohamed A., et al.. (2023). Recent Updates on Synthetic Strategies of Chalcone Scaffold and their Heterocyclic Derivatives. 0(0). 124–132. 3 indexed citations
6.
Bender, Onur, Jonaid Ahmad Malik, Arzu Atalay, et al.. (2023). Combination of an Oxindole Derivative with (−)-β-Elemene Alters Cell Death Pathways in FLT3/ITD+ Acute Myeloid Leukemia Cells. Molecules. 28(13). 5253–5253. 3 indexed citations
7.
Abuo‐Rahma, Gamal El‐Din A., Montaser Sh. A. Shaykoon, Adel A. Marzouk, et al.. (2023). Design, synthesis, cytotoxic activities, and molecular docking of chalcone hybrids bearing 8-hydroxyquinoline moiety with dual tubulin/EGFR kinase inhibition. Bioorganic Chemistry. 134. 106444–106444. 20 indexed citations
8.
Hassan, Heba A., et al.. (2023). The main biotargets of indole or 2-oxoindole-based hybrids acting as promising antiproliferative agents. 6(4). 174–183. 3 indexed citations
9.
Ali, Taha F. S., et al.. (2023). Indole-based FLT3 inhibitors and related scaffolds as potential therapeutic agents for acute myeloid leukemia. BMC Chemistry. 17(1). 73–73. 13 indexed citations
10.
Mustafa, Muhamad, et al.. (2022). Design and Synthesis of New Hydantoin Acetanilide Derivatives as Anti-NSCLC Targeting EGFRL858R/T790M Mutations. Pharmaceuticals. 15(7). 857–857. 5 indexed citations
11.
Ali, Taha F. S., Ryoko Koga, Mohamed O. Radwan, et al.. (2020). HSP70 induction by bleomycin metal core analogs. Bioorganic & Medicinal Chemistry Letters. 30(7). 127002–127002. 2 indexed citations
12.
Gouda, Ahmed M., et al.. (2019). Arylpropionic acid-derived NSAIDs: New insights on derivatization, anticancer activity and potential mechanism of action. Bioorganic Chemistry. 92. 103224–103224. 36 indexed citations
13.
Beshr, Eman A. M., et al.. (2018). Spirohydantoins and 1,2,4-triazole-3-carboxamide derivatives as inhibitors of histone deacetylase: Design, synthesis, and biological evaluation. European Journal of Medicinal Chemistry. 146. 79–92. 32 indexed citations
14.
Balata, Gehan F., et al.. (2017). A qualitative study to improve the student learning experience. Quality Assurance in Education. 25(4). 462–474. 2 indexed citations
15.
Abbas, Samar H., Gamal El‐Din A. Abuo‐Rahma, Mohamed Abdel‐Aziz, et al.. (2016). Synthesis, cytotoxic activity, and tubulin polymerization inhibitory activity of new pyrrol-2(3H)-ones and pyridazin-3(2H)-ones. Bioorganic Chemistry. 66. 46–62. 29 indexed citations
16.
Ali, Taha F. S., Halil I. Ciftci, Ryoko Koga, et al.. (2015). Novel metal chelating molecules with anticancer activity. Striking effect of the imidazole substitution of the histidine–pyridine–histidine system. Bioorganic & Medicinal Chemistry. 23(17). 5476–5482. 18 indexed citations
17.
18.
Abuo‐Rahma, Gamal El‐Din A., Mohamed Abdel‐Aziz, Eman A. M. Beshr, & Taha F. S. Ali. (2013). 1,2,4-Triazole/oxime hybrids as new strategy for nitric oxide donors: Synthesis, anti-inflammatory, ulceroginicity and antiproliferative activities. European Journal of Medicinal Chemistry. 71. 185–198. 64 indexed citations
19.
Abdel‐Aziz, Mohamed, Gamal El‐Din A. Abuo‐Rahma, Eman A. M. Beshr, & Taha F. S. Ali. (2013). New nitric oxide donating 1,2,4-triazole/oxime hybrids: Synthesis, investigation of anti-inflammatory, ulceroginic liability and antiproliferative activities. Bioorganic & Medicinal Chemistry. 21(13). 3839–3849. 42 indexed citations
20.
Mourad, Aboul‐Fetouh E., Ashraf A. Aly, Hassan H. Farag, & Eman A. M. Beshr. (2007). Microwave assisted synthesis of triazoloquinazolinones and benzimidazoquinazolinones. Beilstein Journal of Organic Chemistry. 3. 11–11. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026